Approval · Notice of Compliance 8331 · 2006

KEFUROX: Notice of Compliance 8331

Issued October 18, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 8331
Date: October 18, 2006
Company: Pharmaceutical Partners Of Canada, A Division Of Abraxis Bioscience Inc.
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Antibiotic

Products in this notice

Brand	DIN	Status today
KEFUROX	01927256	Cancelled Post Market
KEFUROX	01927264	Cancelled Post Market
KEFUROX	01986082	Cancelled Post Market

Medicinal ingredients

CEFUROXIME SODIUM 750 MG per VIAL
CEFUROXIME SODIUM 1.5 G per VIAL
CEFUROXIME SODIUM 7.5 G per VIAL